The role of glutathione-S-transferase polymorphisms in ovarian cancer survival

European Journal of Cancer

Volumn 43, Issue 2, 2007, Pages 283-290

  Nagle, Christina M ^a   Chenevix Trench, Georgia ^a   Spurdle, Amanda B ^a   Webb, Penelope M ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Glututathione S transferase; Ovarian cancer; Survival

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER SURVIVAL; DNA EXTRACTION; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HOMOZYGOTE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; SURVIVAL ANALYSIS;

EID: 33846272795     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.09.011     Document Type: Article

References (33)

1. Guppy A.E., Nathan P.D., and Rustin G.J. Epithelial ovarian cancer: a review of current management. Clin Oncol 17 (2005) 399-411
2. Heintz A.P., Odicino F., Maisonneuve P., et al. Carcinoma of the ovary. Int J Gynaecol Obstet 83 Suppl. 1 (2003) 135-166
3. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20 (2002) 1248-1259
4. Berchuck A., Iversen E.S., Lancaster J.M., et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res 11 (2005) 3686-3696
5. Medeiros R., Pereira D., Afonso N., et al. Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome. Int J Clin Oncol 8 (2003) 156-161
6. Strange R.C., Spiteri M.A., Ramachandran S., and Fryer A.A. Glutathione-S-transferase family of enzymes. Mutat Res 482 (2001) 21-26
7. Ban N., Takahashi Y., Takayama T., et al. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Res 56 (1996) 3577-3582
8. Garte S., Gaspari L., Alexandrie A.K., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10 (2001) 1239-1248
9. Rebbeck T.R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6 (1997) 733-743
10. Ali-Osman F., Akande O., Antoun G., Mao J.X., and Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272 (1997) 10004-10012
11. Harries L.W., Stubbins M.J., Forman D., Howard G.C., and Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18 (1997) 641-644
12. Zimniak P., Nanduri B., Pikula S., et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 224 (1994) 893-899
13. Board P.G. Biochemical genetics of glutathione-S-transferase in man. Am J Hum Genet 33 (1981) 36-43
14. Pemble S., Schroeder K.R., Spencer S.R., et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300 (1994) 271-276
15. Seidegard J., Vorachek W.R., Pero R.W., and Pearson W.R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85 (1988) 7293-7297
16. Stoehlmacher J., Park D.J., Zhang W., et al. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst 94 (2002) 936-942
17. Yang G., Shu X.O., Ruan Z.X., et al. Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma. Cancer 103 (2005) 52-58
18. Beeghly A., Katsaros D., Chen H., et al. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecol Oncol 100 (2006) 330-337
19. Mayr D., Pannekamp U., Baretton G.B., et al. Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas. Pathol Res Pract 196 (2000) 469-475
20. Satoh T., Nishida M., Tsunoda H., and Kubo T. Expression of glutathione S-transferase pi (GST-pi) in human malignant ovarian tumours. Eur J Obstet Gynecol Reprod Biol 96 (2001) 202-208
21. Goto S., Iida T., Cho S., Oka M., Kohno S., and Kondo T. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radic Res 31 (1999) 549-558
22. Harpole D.H., Moore M.B., Herndon J.E., et al. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. Clin Cancer Res 7 (2001) 562-569
23. Surowiak P., Materna V., Kaplenko I., et al. Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients. Virchows Archiv 447 (2005) 626-633
24. van der Zee A.G., Hollema H., Suurmeijer A.J., et al. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas. J Clin Oncology 13 (1995) 70-78
25. Ikeda K., Sakai K., Yamamoto R., et al. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer. Int J Gynecol Cancer 13 (2003) 776-784
26. Purdie D., Green A., Bain C., et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer 62 (1995) 678-684
27. Spurdle A.B., Purdie D.M., Webb P.M., Chen X., Green A., and Chenevix-Trench G. The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer. Mol Carcinog 30 (2001) 71-78
28. Spurdle A.B., Webb P.M., Purdie D.M., Chen X., Green A., and Chenevix-Trench G. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 22 (2001) 67-72
29. Lallas T.A., McClain S.K., Shahin M.S., and Buller R.E. The glutathione S-transferase M1 genotype in ovarian cancer. Cancer Epidemiol Biomarkers Prev 9 (2000) 587-590
30. Wrigley E.C., McGown A.T., Buckley H., Hall A., and Crowther D. Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome. Br J Cancer 73 (1996) 763-769
31. Howells R.E., Redman C.W., Dhar K.K., et al. Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer. Clin Cancer Res 4 (1998) 2439-2445
32. Howells R.E., Dhar K.K., Hoban P.R., et al. Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer. Int J Gynecol Cancer 14 (2004) 242-250
33. Johansson A.S., Stenberg G., Widersten M., and Mannervik B. Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J Mol Biol 78 (1998) 687-698